Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Omega-3 supplement to protect thinking skills in people with depression

Tests an omega-3 supplement against soybean oil in older adults with major depression.

Plain-language title generated from the registry record
Registry title: Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice

Key facts

Where
Taichung, TaiwanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 80 years old?

Source: NCT07462013, who can take part

Where in Taiwan

  • Mind-Body Interface Research Center (MBI Lab & Care)Taichung, TaiwanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
National Science and Technology Council, Taiwan
Trial code
NCT07462013
Record updated
17 June 2026
Original description
POWER project is a randomized, controlled, non-profit study with the primary objective of testing the effectiveness of non-pharmacological interventions-such as physical activity, cognitive training, and dietary supplementation-in reducing depressive symptoms and preventing or delaying cognitive impairments that frequently co-occur in individuals with Major Depressive Disorder (MDD).Read full original descriptionShow less

Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice (POWER)

POWER project is a randomized, controlled, non-profit study with the primary objective of testing the effectiveness of non-pharmacological interventions-such as physical activity, cognitive training, and dietary supplementation-in reducing depressive symptoms and preventing or delaying cognitive impairments that frequently co-occur in individuals with Major Depressive Disorder (MDD).

Inclusion: Aged 50-80 years old; Major Depressive Disorder; Absence or mild cognitive impairment.

Exclusion: -.

ClinicalTrials.gov NCT07462013